LAV Biosciences Fund V, L.P. — SEC insider filings

SEC reporting owner CIK 1764435. 2 insider filings on record with FilingPulse; latest filed 2026-09-29.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2026-09-24 to 2026-09-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ADARx Pharmaceuticals, Inc. (ADRX)10% owner2——12

Insider filings — LAV Biosciences Fund V, L.P.

FiledFormIssuerReported transactionsSource
2026-09-294ADARx Pharmaceuticals, Inc. (ADRX)
jointly with LAV Fund VI Opportunities, L.P., LAV Fund VI, L.P.
Conversion (C): 8,908,775 · Conversion (C): 1,667,469 · Conversion (C): 513,067 · Conversion (C): 153,868 · Conversion (C): 307,738 · Conversion (C): 307,738 · +6 moreEDGAR
2026-09-243ADARx Pharmaceuticals, Inc. (ADRX)
jointly with LAV Fund VI Opportunities, L.P., LAV Fund VI, L.P.
Holdings only — no transactions reportedEDGAR

FilingPulse's Form 4 archive currently extends back to 2023-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1764435 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →